ESR1 and pituitary tumor: The rationale for evaluating the effect of anti-estrogens on prolactinomas stems from the following findings: although pituitary tumors have been found to express estrogen receptors [8,19], some studies have shown no change in the size or behavior of pituitary tumors when exposed to high estrogen levels such as during pregnancy or exogenous steroid administration [13].